Cash and Cash Equivalents, at Carrying Value in GBP of TC BioPharm (Holdings) plc from Q4 2022 to Q4 2024

Taxonomy & unit
us-gaap: GBP and USD
Description
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Summary
TC BioPharm (Holdings) plc quarterly Cash and Cash Equivalents, at Carrying Value history and change rate from Q4 2022 to Q4 2024.
  • TC BioPharm (Holdings) plc Cash and Cash Equivalents, at Carrying Value for the quarter ending 31 Dec 2024 was £1.22M, a 50.6% decline year-over-year.
Cash and Cash Equivalents, at Carrying Value, Quarterly (GBP)
Cash and Cash Equivalents, at Carrying Value, YoY Quarterly Change (%)

TC BioPharm (Holdings) plc Quarterly Cash and Cash Equivalents, at Carrying Value (GBP)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 1.22M -1.25M -50.6% 31 Dec 2024 20-F 09 May 2025
Q2 2024 1M 30 Jun 2024 6-K 25 Nov 2024
Q1 2024 981K 31 Mar 2024 10-Q 15 May 2024
Q4 2023 2.46M -2.35M -48.8% 31 Dec 2023 20-F 09 May 2025
Q4 2022 4.81M 31 Dec 2022 10-K 01 Apr 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.